Close

Merck (MRK) Surges After Bristol-Myers Squibb's (BMY) CheckMate -026 Trial Fails

August 5, 2016 8:24 AM EDT Send to a Friend
(Updated)Shares of Merck (NYSE: MRK) surged pre-market Friday after Bristol-Myers Squibb (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login